Zoloft Solution, Concentrate
NDC Package 58151-601-35
Package Information
Zoloft (sertraline hydrochloride) solution is sertraline is used to treat depression, panic attacks, obsessive compulsive disorder, post-traumatic stress disorder, social anxiety disorder (social phobia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This formulation utilizes a solution, concentrate delivery system. Marketed by Viatris Specialty Llc, this product is identified by NDC 58151-601 and is authorized under FDA application NDA020990.
Identification & Billing
- RxCUI: 208149 - Zoloft 100 MG Oral Tablet
- RxCUI: 208149 - sertraline 100 MG Oral Tablet [Zoloft]
- RxCUI: 208149 - Zoloft (as sertraline hydrochloride) 100 MG Oral Tablet
- RxCUI: 208161 - Zoloft 50 MG Oral Tablet
- RxCUI: 208161 - sertraline 50 MG Oral Tablet [Zoloft]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58151 - Viatris Specialty Llc
- 58151-601 - Zoloft
- 58151-601-35 - 1 BOTTLE, DROPPER in 1 CARTON / 60 mL in 1 BOTTLE, DROPPER
- 58151-601 - Zoloft
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58151-601-35 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 60 ml in 1 bottle, dropper of Zoloft, a human prescription drug labeled by Viatris Specialty Llc. This solution, concentrate is formulated for oral use and contains sertraline hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Viatris Specialty Llc on November 21, 2024. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Sertraline is used to treat depression, panic attacks, obsessive compulsive disorder, post-traumatic stress disorder, social anxiety disorder (social phobia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Sertraline is known as a selective serotonin reuptake inhibitor (SSRI). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain.
How is this Viatris Specialty Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58151060135. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.